foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound FOX04-DRI - Apollo Peptide Sciences
FOX04 DRI Apollo Peptide Sciences Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC
Pay in 4 interest-free payments of $7.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21



